Sevelamer carbonate

🧮 Dose calculator

Hyperphosphataemia in dialysis · Regimen source: FDA Renvela · 2.1, Table 1

• • Phosphorus >5.5–<7.5: 0.8 g; ≥7.5: 1.6 g three times daily with meals. Titrate by 0.8 g per meal every 2 weeks to target. FDA Renvela · 2.1, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyNo specific problem stated

  Label: minimal systemic absorption; fetal exposure not expected. FDA Renvela · 8.1

  “Risk Summary Sevelamer carbonate is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug.”

• 🤱 BreastfeedingNo specific problem stated

  Label: infant exposure not expected. FDA Renvela · 8.2

  “Risk Summary Renvela is not absorbed systemically by the mother following oral administration, and breastfeeding is not expected to result in exposure of the child to Renvela.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Renvela · 8.4

  “The safety and efficacy of Renvela in lowering serum phosphorus levels was studied in patients 6 years of age and older with CKD.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Renvela · 8.5

  “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.